Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B
about
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson diseaseRasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase BCardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.Adjunctive therapy in Parkinson's disease: the role of rasagiline.DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.Interactions of monoamine oxidase with substrates and inhibitors.The potential use of mechanism-based enzyme inactivators in medicine.Platelet monoamine oxidase B: use and misuse.Selective inhibitors of monoamine oxidase A and B: biochemical, pharmacological, and clinical properties.Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism.Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells.Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide.Monoamine oxidase activity and triiodothyronine biosynthesis in human cultured thyroid cells.limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.Synthetic Aminoindanes: A Summary of Existing Knowledge.Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.Inhibition of monoamine oxidase by phenyl azides.Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism.
P2860
Q28262497-E78DDF82-D1B4-4551-B615-0E7FE45BF696Q28346410-8B1C7BE5-9D4A-4ECE-BF80-327B16D4E07AQ35047710-995B277D-B7B5-4B4D-818F-CCEFC2E90518Q35886520-7AFFBC5B-CA99-4DBC-B77F-F7E4FEC00553Q36128618-A3E06F56-A059-4F46-ACF4-397083226AFCQ38026830-8556639F-AF46-4859-B98C-95E59550BA37Q38223203-5F4EC49B-AE44-4910-B26E-514AB801B5D4Q38601497-A13B0BE5-FC9A-49CE-B814-1E37CE4DFBA9Q39568018-43D0CA9E-1BD9-4073-AD89-90CFD87B5945Q39631444-A05FE232-4F7C-44D7-AE83-69DB539D9A6DQ40182942-3724DEF7-60A6-4E4A-9A0D-E2CAB045073FQ40369097-E57A4E2A-D5C7-40C5-A181-D66E26E6B838Q42050525-8086029E-1BC2-48B5-A43A-B9AE44DDC1C5Q42143803-9F11E0AA-59D5-42A2-A6ED-FA7EB6F7CAA3Q42505396-1F810D0D-9157-455B-84A1-A445B24635F3Q43247357-564777EE-87E5-4328-A764-80AB7FC162D4Q47567624-0B54166D-2A88-43A9-83B5-E38BC52D4434Q48093061-251E3374-E9D9-4D9F-BDE4-316159327523Q48352927-912ED94B-44BF-4B8C-947D-21D8E100BE3DQ48456491-7DCC65AE-D210-4676-A797-713844652476Q55029546-76A9CC18-96B1-4AEB-A97A-8AC40481BBD5
P2860
Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@ast
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@en
type
label
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@ast
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@en
prefLabel
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@ast
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@en
P2093
P2860
P1476
Selective acetylenic 'suicide' ...... onoamine oxidase types A and B
@en
P2093
P2860
P356
10.1111/J.1476-5381.1981.TB16771.X
P407
P577
1981-05-01T00:00:00Z